Zentalis Pharmaceuticals, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| GOEL DAVID E. | — | Sale | 7,500,000 | $1.33 | $9,975,000 | 6,459,973 | Dec 15, 2025 |
| Walker Luke Nathaniel | — | Award / Grant | 57,603 | — | — | 144,284 | Jun 17, 2025 |
| Skvarka Jan | — | Award / Grant | 57,603 | — | — | 207,154 | Jun 17, 2025 |
| Johnson David Michael | — | Award / Grant | 57,603 | — | — | 250,421 | Jun 17, 2025 |
| Kariuki Enoch | — | Award / Grant | 57,603 | — | — | 137,365 | Jun 17, 2025 |
| Myers Scott Dunseth | — | Award / Grant | 57,603 | — | — | 338,795 | Jun 17, 2025 |
| Myers Scott Dunseth | — | Purchase | 21,000 | $1.40 | $29,400 | 281,192 | Apr 30, 2025 |
| Bruns Ingmar | Chief Medical Officer | Purchase | 20,000 | $2.28 | $45,600 | 36,629 | Feb 6, 2025 |
| Vultaggio Vincent | PAO and Interim PFO | Sale | 2,615 | $1.71 | $4,472 | 189,826 | Feb 3, 2025 |
| Lackner Mark | Chief Scientific Officer | Sale | 14,368 | $1.71 | $24,569 | 512,856 | Feb 3, 2025 |
| Paul Andrea | Chief Legal Officer | Sale | 13,230 | $1.71 | $22,623 | 1,070,784 | Feb 3, 2025 |
| Bruns Ingmar | Chief Medical Officer | Award / Grant | 16,629 | — | — | 16,629 | Feb 3, 2025 |
| EASTLAND JULIA MARIE | CEO & President | Award / Grant | 59,388 | — | — | 87,888 | Feb 3, 2025 |
| Skvarka Jan | — | Purchase | 60,000 | $1.72 | $103,200 | 149,551 | Jan 31, 2025 |
| Walker Luke Nathaniel | — | Purchase | 14,200 | $1.76 | $24,992 | 86,681 | Jan 31, 2025 |
| EASTLAND JULIA MARIE | CEO & President | Purchase | 28,500 | $1.73 | $49,305 | 28,500 | Jan 31, 2025 |
| Lackner Mark | Chief Scientific Officer | Sale | 4,411 | $3.12 | $13,762 | 191,317 | Jan 2, 2025 |
| Myers Scott Dunseth | — | Award / Grant | 260,192 | — | — | 260,192 | Nov 13, 2024 |
| Vultaggio Vincent | Principal Accounting Officer | Sale | 1,603 | $3.18 | $5,098 | 33,855 | Oct 4, 2024 |
| Skvarka Jan | — | Award / Grant | 41,581 | — | — | 89,551 | Jun 21, 2024 |
| Kariuki Enoch | — | Award / Grant | 41,581 | — | — | 79,762 | Jun 21, 2024 |
| Johnson David Michael | — | Award / Grant | 48,429 | — | — | 192,818 | Jun 21, 2024 |
| Gallagher Cam | President, Interim CFO | Sale | 9,597 | $11.98 | $114,972 | 633,680 | May 31, 2024 |
| Walker Luke Nathaniel | — | Award / Grant | 72,481 | — | — | 72,481 | May 24, 2024 |
| HAUSMAN DIANA | Chief Medical Officer | Sale | 3,356 | $12.62 | $42,353 | 373,876 | May 9, 2024 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 2,573 | $11.44 | $29,435 | 451,449 | Feb 12, 2024 |
| Gallagher Cam | President | Sale | 1,173 | $11.44 | $13,419 | 643,277 | Feb 12, 2024 |
| Lackner Mark | Chief Scientific Officer | Award / Grant | 141,000 | — | — | 197,313 | Feb 2, 2024 |
| Gallagher Cam | President | Award / Grant | 192,500 | — | — | 656,002 | Feb 2, 2024 |
| HAUSMAN DIANA | Chief Medical Officer | Award / Grant | 337,500 | — | — | 377,232 | Feb 1, 2024 |
| Paul Andrea | Chief Legal Officer | Sale | 3,310 | $11.54 | $38,197 | 149,973 | Feb 1, 2024 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 8,669 | $11.54 | $100,040 | 454,022 | Feb 1, 2024 |
| Blackwell Kimberly | Chief Executive Officer | Tax Withholding | 20,655 | $11.69 | $241,457 | 484,145 | Feb 1, 2024 |
| Lackner Mark | Chief Scientific Officer | Award / Grant | 40,000 | — | — | 56,313 | Jan 2, 2024 |
| Bunker Kevin D. | Chief Scientific Officer | Gift | 24,158 | — | — | 834,931 | Dec 20, 2023 |
| Blackwell Kimberly | Chief Executive Officer | Purchase | 5,000 | $10.29 | $51,450 | 254,800 | Nov 13, 2023 |
| Johnson David Michael | — | Purchase | 17,000 | $9.88 | $167,960 | 144,389 | Nov 10, 2023 |
| Brownstein Carrie | Chief Medical Officer | Sale | 8,906 | $19.43 | $173,044 | 107,407 | Oct 4, 2023 |
| Bunker Kevin D. | Chief Scientific Officer | Sale | 5,085 | $19.43 | $98,802 | 860,072 | Oct 4, 2023 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 4,594 | $19.43 | $89,261 | 388,579 | Oct 4, 2023 |
| Skvarka Jan | — | Sale | 5,000 | $25.05 | $125,250 | 47,970 | Sep 11, 2023 |
| Matrix Capital Management Company, LP | — | Purchase | 4,760,000 | $22.66 | $107,861,600 | 13,959,973 | Jun 20, 2023 |
| Johnson David Michael | — | Award / Grant | 19,059 | — | — | 127,389 | Jun 16, 2023 |
| Kariuki Enoch | — | Award / Grant | 16,364 | — | — | 38,181 | Jun 16, 2023 |
| Skvarka Jan | — | Award / Grant | 16,364 | — | — | 52,970 | Jun 16, 2023 |
| Gallagher Cam | President | Sale | 18,526 | $26.21 | $485,566 | 463,502 | May 31, 2023 |
| Bunker Kevin D. | Chief Scientific Officer | Sale | 80,000 | $30.02 | $2,401,600 | 15,000 | May 26, 2023 |
| HAUSMAN DIANA | — | Award / Grant | 39,732 | — | — | 39,732 | May 8, 2023 |
| Roth Iris | Chief Operating Officer | Award / Grant | 52,500 | — | — | 52,500 | Mar 1, 2023 |
| Epperly Melissa B, | Chief Financial Officer | Sale | 5,227 | $19.98 | $104,435 | 392,048 | Feb 13, 2023 |